Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists.
作者信息
Konig Maximilian F, Powell Mike, Staedtke Verena, Bai Ren-Yuan, Thomas David L, Fischer Nicole, Huq Sakibul, Khalafallah Adham M, Koenecke Allison, Xiong Ruoxuan, Mensh Brett, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Vogelstein Joshua T, Athey Susan, Zhou Shibin, Bettegowda Chetan
机构信息
Ludwig Center.
Lustgarten Laboratory, and.
出版信息
J Clin Invest. 2020 Jul 1;130(7):3345-3347. doi: 10.1172/JCI139642.
Abstract
摘要
相似文献
1
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists.
J Clin Invest. 2020 Jul 1;130(7):3345-3347. doi: 10.1172/JCI139642.
2
Proposed use of thalidomide for the cytokine storm of COVID-19.
Clin Dermatol. 2020 Jul-Aug;38(4):508. doi: 10.1016/j.clindermatol.2020.04.015. Epub 2020 Apr 28.
3
Dapsone and doxycycline could be potential treatment modalities for COVID-19.
Med Hypotheses. 2020 Jul;140:109768. doi: 10.1016/j.mehy.2020.109768. Epub 2020 Apr 22.
4
Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.
In Vivo. 2020 Jun;34(3 Suppl):1589-1592. doi: 10.21873/invivo.11947.
5
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
6
On the Alert for Cytokine Storm: Immunopathology in COVID-19.
Arthritis Rheumatol. 2020 Jul;72(7):1059-1063. doi: 10.1002/art.41285. Epub 2020 May 10.
7
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series.
Crit Care. 2020 Jul 17;24(1):444. doi: 10.1186/s13054-020-03158-0.
8
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Int Immunopharmacol. 2020 Sep;86:106749. doi: 10.1016/j.intimp.2020.106749. Epub 2020 Jul 1.
9
Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.
Br J Haematol. 2020 Aug;190(3):e150-e154. doi: 10.1111/bjh.16961. Epub 2020 Jul 16.
10
[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?].
Cancer Radiother. 2020 Jun;24(3):179-181. doi: 10.1016/j.canrad.2020.04.003. Epub 2020 May 1.
引用本文的文献
1
Dexmedetomidine potently and reversibly regulates stress-mediated behaviors.
Front Pharmacol. 2025 Jul 2;16:1589075. doi: 10.3389/fphar.2025.1589075. eCollection 2025.
2
Composite Autonomic Symptom Score-31 for the diagnosis of cardiovascular autonomic dysfunction in long-term coronavirus disease 2019.
J Family Community Med. 2024 Jul-Sep;31(3):214-221. doi: 10.4103/jfcm.jfcm_20_24. Epub 2024 Jul 17.
3
The Interplay of HIV and Long COVID in Sub-Saharan Africa: Mechanisms of Endothelial Dysfunction.
Curr Cardiol Rep. 2024 Sep;26(9):859-871. doi: 10.1007/s11886-024-02087-6. Epub 2024 Jul 3.
4
Inflammation-based Scores in Patients With Pheochromocytoma.
J Clin Endocrinol Metab. 2025 Feb 18;110(3):e630-e640. doi: 10.1210/clinem/dgae284.
5
Disease phenotypic screening in neuron-glia cocultures identifies blockers of inflammatory neurodegeneration.
iScience. 2024 Mar 8;27(4):109454. doi: 10.1016/j.isci.2024.109454. eCollection 2024 Apr 19.
6
Autonomic dysregulation in long-term patients suffering from Post-COVID-19 Syndrome assessed by heart rate variability.
Sci Rep. 2023 Sep 22;13(1):15814. doi: 10.1038/s41598-023-42615-y.
7
Effects of COVID-19 on the Autonomic Cardiovascular System: Heart Rate Variability and Turbulence in Recovered Patients.
Tex Heart Inst J. 2023 Aug 21;50(4). doi: 10.14503/THIJ-22-7952.
8
Autonomic modulation, spontaneous baroreflex sensitivity and fatigue in young men after COVID-19.
Physiol Res. 2023 Jul 14;72(3):329-336. doi: 10.33549/physiolres.935051.
9
Autoimmunity in Long Covid and POTS.
Oxf Open Immunol. 2023 Mar 8;4(1):iqad002. doi: 10.1093/oxfimm/iqad002. eCollection 2023.
10
An Unusual Case of Blackout in a COVID-19 Patient: COVID-19 Brain Fog.
Cureus. 2023 Mar 17;15(3):e36273. doi: 10.7759/cureus.36273. eCollection 2023 Mar.
本文引用的文献
1
Effective treatment of severe COVID-19 patients with tocilizumab.
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
2
Tocilizumab treatment in COVID-19: A single center experience.
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
3
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.
Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
4
Clinical and immunological features of severe and moderate coronavirus disease 2019.
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
5
SARS-CoV-2: a storm is raging.
J Clin Invest. 2020 May 1;130(5):2202-2205. doi: 10.1172/JCI137647.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
9
COVID-19 and the cardiovascular system.
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
10
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
Zotero 插件